TAIPEI, Oct. 22, 2024 /PRNewswire/ -- Cordyceps Sunshine Biotech Holdings Co., Ltd. ã€C.S】Group, recognized for its expertise in cultivating the rare medicinal fungus Taiwanofungus, native to Taiwan, has reached a significant milestone by uplisting to the OTCQB market.
Aiming for a Future Nasdaq Listing
The transition to the OTCQB represents an important initial achievement for ã€C.S】Group. While OTC Markets generally offer lower trading volumes compared to more centralized exchanges, the OTCQB serves as a strategic entry point for companies with ambitions to meet the criteria for future uplisting to major exchanges like Nasdaq. Known for hosting emerging companies, OTC Markets also includes several global giants such as Roche, Bayer, Nestlé, and Allianz, which adds to its diverse ecosystem.
The OTC Markets is segmented into three tiers: OTCQX, OTCQB, and the Pink Market, with OTCQB and OTCQX requiring compliance with SEC registration and consistent financial disclosures in accordance with the U.S. Securities Exchange Act of 1934. By advancing to OTCQB, ã€C.S】Group showcases its dedication to maintaining transparency and adhering to U.S. regulatory standards, positioning the company for continued growth.
Strategic Vision and Market Expansion
ã€C.S】Group's move to OTCQB reflects its readiness to align with the financial transparency and regulatory requirements of U.S. capital markets. Utilizing its proprietary cultivation technology, ã€C.S】Group has achieved large-scale production of Taiwanofungus, with major facilities established in Taiwan. This enables the company to cater to the increasing demand for herbal and medicinal products across the Asia-Pacific region. With a strong foundation in place, ã€C.S】Group expects to realize significant revenue growth and is preparing for a potential Nasdaq listing in the future, further enhancing its market presence and global reach.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
【C.S】Cordyceps Sunshine Biotech Uplists to OTCQB, Aims for a Potential Nasdaq Uplisting
Launched to mark the company's 10th anniversary, Osara Health's Global Cancer Support Declaration has already secured signatures from healthcare professionals worldwide.
NEW YORK, Aug. 12, 2026 /PRNewswire/ -- Osara Health, a global digital health company focused on the human experience of cancer care, marks 10 years since its founding with 527 healthcare professionals signing its Global Cancer Support Declaration.
Launched earlier this year, the declaration calls for people living with and beyond cancer to receive support that extends beyond treatment. Signatories include oncologists and cancer specialists worldwide, with a goal of 2,000 signatures by year-end.
Founded in 2016, Osara Health delivers cancer support programs through leading insurers and employers across the United States, Canada, Australia, and New Zealand.
The milestone comes as cancer's impact on working-age populations grows. 45% of cancer diagnoses occur during working life, while improving survival means more people are living with and beyond cancer.
Today, Osara Health supports more than 11 million covered lives through partnerships with organizations including MetLife, Manulife, Guardian, Allstate Benefits, nib, GMHBA, and UniMed. Its programs are backed by more than 11 peer-reviewed studies, including recent findings published in JMIR Cancer in 2026 showing significant improvements in physical and mental health outcomes.
"As an oncologist, I watched people receive excellent treatment and then return home to manage fear, fatigue, work, and family largely on their own. Osara Health was founded to address the human side of cancer: how people feel, function, and live after diagnosis. Seeing colleagues around the world put their names to that belief is the best anniversary gift we could ask for," said Dr Raghav Murali-Ganesh, CEO, Co-Founder of Osara Health, and Radiation Oncologist.
"We started with an app, but the lesson of our first decade is simple: people do better when someone is in their corner between appointments," said Tim Atkins, Co-Founder and COO of Osara Health. "The declaration is an invitation to make that support standard, wherever someone is diagnosed."
To mark the anniversary, Osara Health has released 10 Years Supporting the Human Side of Cancer, available at https://osarahealth.com/2026-declaration.
About Osara Health
Osara Health is a global digital health company transforming the human side of cancer care through evidence-based behavior change science, human coaching, and digital tools. Learn more at osarahealth.com.
Media Contact
Paul Oganyan, Senior Marketing Manager
marketing@osarahealth.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Osara Health Marks 10 Years with Global Call to Make Cancer Support Beyond Treatment Standard
